ENDPOINTS NEWS31m
No­vo ex­pands pact with Flag­ship's Va­lo to in­clude obe­si­ty, di­a­betes for $190M near-term
Novo Nordisk is doubling down on its computational biotech partner Valo Health, expanding their collaboration from 11 ...